SCHEMBL19913336

SCHEMBL19913336

N#Cc1cc(-n2c3ccccc3c3c(-c4ccccc4-c4ccccc4)cccc32)c(-c2cc(-c3ccccc3)nc(-c3ccccc3)c2)c(-n2c3ccccc3c3c(-c4ccccc4-c4ccccc4)cccc32)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 2/20 0.37
ABCB1 P08183 1/20 0.37
SQOR Q9Y6N5 4/20 0.36
GABRG2 P18507 4/20 0.36
GABRB3 P28472 4/20 0.36
GABRA5 P31644 4/20 0.36
GABRA3 P34903 4/20 0.36
GABRA1 P14867 2/20 0.36
ADORA2A P29274 2/20 0.35
ADORA1 P30542 2/20 0.35
MAPK1 P28482 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MYC P01106 1/20 0.35
KDM4E B2RXH2 2/20 0.34
HPGD P15428 2/20 0.34
NPSR1 Q6W5P4 2/20 0.34
PPARG P37231 1/20 0.34
NCOA2 Q15596 1/20 0.34
NCOA1 Q15788 1/20 0.34
NCOA3 Q9Y6Q9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19913334 0.86 HPGD (0.36) ABCG2SQORKDM4EHPGDCNR2
SCHEMBL19913337 0.86 MYC (0.38) ABCG2ABCB1SQORGABRG2GABRB3
SCHEMBL19913333 0.86 MYC (0.38) ABCG2ABCB1SQORGABRG2GABRB3
SCHEMBL19909477 0.85 SQOR (0.43) SQORADORA2AADORA1MAPK1L3MBTL1
SCHEMBL22170438 0.84 GABRG2 (0.39) ABCG2ABCB1SQORGABRG2GABRB3
SCHEMBL19913329 0.84 GABRG2 (0.39) ABCG2ABCB1SQORGABRG2GABRB3
SCHEMBL19919659 0.83 GABRG2 (0.38) ABCG2ABCB1SQORGABRG2GABRB3
SCHEMBL19909543 0.81 ABCG2 (0.40) ABCG2ABCB1SQORGABRG2GABRB3
SCHEMBL19913339 0.81 SQOR (0.39) SQORADORA2AADORA1MAPK1L3MBTL1
SCHEMBL19909175 0.81 MYC (0.42) ABCG2ABCB1SQORGABRG2GABRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588114-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-21 US disclosed
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-07-02 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OPRM1, OR51E2 ABCG2 624/4885ABCB1 161/4885SQOR 1580/4885
US-11588114-B2 Organic molecules for use in optoelectronic devices OR10J3, OPRM1, OR51E2 ABCG2 624/4885ABCB1 161/4885SQOR 1580/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.